Julia A. Smith, MD, PhD | Authors

Clinical Hereditary Cancer Syndromes and Gene Panel Testing

October 15, 2016

For some time, genetic testing has been predictive and prognostic. It is now assuming a therapeutic role as well. An example is the targeting of breast cancer patients with BRCA mutations for treatment with PARP inhibitors.